Search

Search Constraints

You searched for: Author/Creator Ference, Brian A

Search Results

1. 2019 ESC/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk: The Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and European Atherosclerosis Society (EAS). (31st August 2019)

3. Is the SMART risk prediction model ready for real-world implementation? A validation study in a routine care setting of approximately 380 000 individuals. (23rd June 2021)

4. Lipoprotein(a) in atherosclerotic cardiovascular disease and aortic stenosis: a European Atherosclerosis Society consensus statement . (18th August 2022)

5. Low-density lipoproteins cause atherosclerotic cardiovascular disease: pathophysiological, genetic, and therapeutic insights: a consensus statement from the European Atherosclerosis Society Consensus Panel. (13th February 2020)

6. New prospects for PCSK9 inhibition?. (22nd March 2018)

7. Population genomic screening of young adults for familial hypercholesterolaemia: a cost-effectiveness analysis . (11th November 2021)

9. Triglyceride-rich lipoproteins and their remnants: metabolic insights, role in atherosclerotic cardiovascular disease, and emerging therapeutic strategies—a consensus statement from the European Atherosclerosis Society. (2nd September 2021)